兴发娱乐

    Vascular Ultrasound Q&A with Leading Experts in Vascular Sonography

    10-07-2024

    You asked, and our experts answered!  Our most recent Vascular CME Webinar was a success and Mindray is pleased to present the following questions and answers from that session to share with you and with our Mindray Insiders!
    \r\n"}}" id="text-f33281b18f" class="8f00b2 cmp-text">
    You asked, and our experts answered!  Our most recent Vascular CME Webinar was a success and Mindray is pleased to present the following questions and answers from that session to share with you and with our Mindray Insiders!

    Volumetric Flow Rate Q&A
    with Vascular Sonography Expert
    Tony Smet, BS, RDMS, RVT

    Educator and Vascular Sonographer
    \r\nSan Leandro, California

    \r\n


    \r\nAfter serving eight years of service at home and abroad in the Air Force, Tony Smet decided to make a new career in Vascular Technology. He specializes in noninvasive vascular procedures including: cerebrovascular, arterial peripheral imaging and physiological testing, upper and lower peripheral venous imaging, dialysis access imaging, renal hemodynamic testing and abdominal arterial and venous imaging.

    \r\n"}}" id="text-7d3292593e" class="8f00b2 cmp-text">

    Educator and Vascular Sonographer
    San Leandro, California


    After serving eight years of service at home and abroad in the Air Force, Tony Smet decided to make a new career in Vascular Technology. He specializes in noninvasive vascular procedures including: cerebrovascular, arterial peripheral imaging and physiological testing, upper and lower peripheral venous imaging, dialysis access imaging, renal hemodynamic testing and abdominal arterial and venous imaging.

    Tony Smet, BS, RDMS, RVT

    1. AVF volume flow measurements: Don't you need to place an angle parallel to the vessel?

    The Volumetric Flow Rate auto measurement feature on the system I use removes the angle correction line (after you angle correct) from the center of the lumen and places it at the walls to ensure you are true to the wall.   

    2.  Is obtaining three cycles absolutely necessary for flow volume?
    \r\n\r\n

    Best practice is to obtain at least 3, but you can obtain more. The white paper methods described three to five waveforms as being acceptable. This is because are obtaining an average velocity, so we want to average at least three waveforms for accuracy.

    \r\n

     

    \r\n

    3.  What is the criteria of AVF stenosis?
    \r\n

    \r\n

    There are several published peer reviewed criteria. Your lab leadership needs to determine what criteria they would like to use.

    \r\n

     

    \r\n

    4. Why is there no cursor in the dialysis access Doppler images? Are we not supposed to use a cursor indicating a 60-degree angle?

    \r\n

    The Volumetric Flow Rate auto measurement feature on the system I use removes the angle correction line (after you angle correct) from the center of the lumen and places it at the walls to ensure you are true to the wall.
    \r\n

    \r\n

     

    \r\n

    5. Why is color Doppler not used for the VFR evaluations? Are there diameter parameters for an accurate VFR?

    \r\n

    Color is not used so the walls can be clearly identified/acquired and measured precisely.

    \r\n

     

    \r\n

    6. What happens if my sample volume/ gate is outer to the outer wall when measuring VFR?

    \r\n

    Having the sample gate outside the wall, or even into the tissue will not significantly alter your Volumetric Flow Rate, however, could create instability in your Doppler spectra due to wall noise the machine will pick up when the vessel pulses.

    \r\n

     

    \r\n

    7. If intimal thickening is present, do you measure the residual lumen?

    \r\n

    Yes, the lumen diameter is to be measured. Optimally, a different location, without wall abnormalities is chosen to capture the measurements.

    \r\n

     

    \r\n

    8. What does it mean if the volumetric flow rate is really high or really low?

    \r\n

    There are many reasons for high or low VFR. Reasons for high VFR could be a large diameter, an overactive access, or tech error (sample volume not open and only capturing highest velocities in calculation). Low VFR could be attributed to a severe stenosis limiting flow, a small access that has not yet matured, or underestimating the diameter of the access.

    \r\n

     

    \r\n

    9. What should you do if there is not a straight segment, or the entire segment is aneurysmal?

    \r\n

    Some dialysis accesses do not have an ideal segment to measure. You can create a lab policy with your leadership to decide if they want you to take a VFR and note it is over/underestimated or decide to not take the measurement. This should be noted in the report, so it is understood as well.

    \r\n"}}" id="text-91477708d5" class="8f00b2 cmp-text">

    2.  Is obtaining three cycles absolutely necessary for flow volume?

    Best practice is to obtain at least 3, but you can obtain more. The white paper methods described three to five waveforms as being acceptable. This is because are obtaining an average velocity, so we want to average at least three waveforms for accuracy.

     

    3.  What is the criteria of AVF stenosis?

    There are several published peer reviewed criteria. Your lab leadership needs to determine what criteria they would like to use.

     

    4. Why is there no cursor in the dialysis access Doppler images? Are we not supposed to use a cursor indicating a 60-degree angle?

    The Volumetric Flow Rate auto measurement feature on the system I use removes the angle correction line (after you angle correct) from the center of the lumen and places it at the walls to ensure you are true to the wall.

     

    5. Why is color Doppler not used for the VFR evaluations? Are there diameter parameters for an accurate VFR?

    Color is not used so the walls can be clearly identified/acquired and measured precisely.

     

    6. What happens if my sample volume/ gate is outer to the outer wall when measuring VFR?

    Having the sample gate outside the wall, or even into the tissue will not significantly alter your Volumetric Flow Rate, however, could create instability in your Doppler spectra due to wall noise the machine will pick up when the vessel pulses.

     

    7. If intimal thickening is present, do you measure the residual lumen?

    Yes, the lumen diameter is to be measured. Optimally, a different location, without wall abnormalities is chosen to capture the measurements.

     

    8. What does it mean if the volumetric flow rate is really high or really low?

    There are many reasons for high or low VFR. Reasons for high VFR could be a large diameter, an overactive access, or tech error (sample volume not open and only capturing highest velocities in calculation). Low VFR could be attributed to a severe stenosis limiting flow, a small access that has not yet matured, or underestimating the diameter of the access.

     

    9. What should you do if there is not a straight segment, or the entire segment is aneurysmal?

    Some dialysis accesses do not have an ideal segment to measure. You can create a lab policy with your leadership to decide if they want you to take a VFR and note it is over/underestimated or decide to not take the measurement. This should be noted in the report, so it is understood as well.

    Peripheral Arterial Duplex Ultrasound Q&A
    with Vascular Sonography Expert
    Laurie Lozanski, RVT, RVS, CCI

    Educator and Vascular Sonographer
    \r\n Chicago, IL

    \r\n


    \r\nLaurie Lozanski is an adjunct faculty member for the College of Health Science at Rush University in Chicago where she serves on the Vascular Ultrasound Board of Advisors and has been teaching vascular ultrasound to undergraduates for 20 years. She also holds the position of Technical Director of the Non-invasive Vascular Laboratory at the University of Chicago and has co-authored two textbooks on vascular ultrasound and presented at national meetings.
    \r\n

    \r\n"}}" id="text-ec1e29233c" class="8f00b2 cmp-text">

    Educator and Vascular Sonographer
    Chicago, IL


    Laurie Lozanski is an adjunct faculty member for the College of Health Science at Rush University in Chicago where she serves on the Vascular Ultrasound Board of Advisors and has been teaching vascular ultrasound to undergraduates for 20 years. She also holds the position of Technical Director of the Non-invasive Vascular Laboratory at the University of Chicago and has co-authored two textbooks on vascular ultrasound and presented at national meetings.

    Laurie Lozanski, RVT, RVS, CCI

    1. Is it possible to have low resistance and high velocity at the same time? 

    Yes, examples include flow in a dialysis access or in an arteriovenous fistula occurring as a complication after a procedure (like cardiac cath puncture). You also have low resistance and high velocity in ICA stenosis or any artery that normally feeds a low-resistance bed but has a stenosis (remember many organs are “low resistance” and so they have low resistance waveforms normally because they need constant flow like the brain, kidney, spleen etc.)

    2.  Should you not do a color invert, when you see blue color in deep Femoral Artery?
    \r\n\r\n

    You shouldn’t automatically invert your color just because you know the flow should be “red” or towards the feet, away from the heart for example. Before you do, orient yourself and try to understand what is happening with the flow. Maybe there is an occlusion above the segment and the artery is acting as a collateral as the example illustrated in the talk. It is vital that each vascular sonographer be able to determine flow direction in any vessel. If the flow is reversed in direction, it should be shown as reversed (blue) in both color and waveform on the spectral tracing so that anyone who looks at the image can see that there is reversal of flow.

    \r\n

     

    \r\n

    3. When measuring aneurysms, do measurements in AP and TRANS or is it more correct to measure AP, TRANS, and LONG?

    \r\n

    Measure in AP and LONG for sure. Check what your interpreting MDs think about measuring the length of the aneurysm since some surgeons no longer think this is an important measurement to regularly measure. What might be more important is the distance from the renal arteries when you have a AAA because this helps the surgeon decide whether they have to use stents into the renals or if there is enough room for them to have a proximal attachment site that doesn’t interfere with renal flow.

    \r\n

     

    \r\n

    4. Should we invert the color and waveform when we see reversed flow throughout a vessel?

    \r\n

    It is vital that each vascular sonographer be able to determine flow direction in any vessel. If the flow is reversed in direction, it should be shown as reversed (blue) in both color and waveform so that anyone who looks at the image can see that there is reversal of flow. Then it can be determined as to why.

    \r\n

     

    \r\n

    5. What is the major concern in peripheral aneurysms?

    \r\n

    Blood clots and distal emboli.

    \r\n

     

    \r\n

    6. Which flow condition is the most common site for arterial disease development?

    \r\n

    Flow at branch points.

    \r\n

     

    \r\n

    7. What could be the cause of the spectral window filling on the PW doppler trace?

    \r\n

     There could be several causes:

    \r\n

    - Doppler gain is too high

    \r\n

    - Sample gate is placed at an area of flow separation

    \r\n

    - Reynold’s number is greater than 4000.

    \r\n"}}" id="text-b4234afe31" class="8f00b2 cmp-text">

    2.  Should you not do a color invert, when you see blue color in deep Femoral Artery?

    You shouldn’t automatically invert your color just because you know the flow should be “red” or towards the feet, away from the heart for example. Before you do, orient yourself and try to understand what is happening with the flow. Maybe there is an occlusion above the segment and the artery is acting as a collateral as the example illustrated in the talk. It is vital that each vascular sonographer be able to determine flow direction in any vessel. If the flow is reversed in direction, it should be shown as reversed (blue) in both color and waveform on the spectral tracing so that anyone who looks at the image can see that there is reversal of flow.

     

    3. When measuring aneurysms, do measurements in AP and TRANS or is it more correct to measure AP, TRANS, and LONG?

    Measure in AP and LONG for sure. Check what your interpreting MDs think about measuring the length of the aneurysm since some surgeons no longer think this is an important measurement to regularly measure. What might be more important is the distance from the renal arteries when you have a AAA because this helps the surgeon decide whether they have to use stents into the renals or if there is enough room for them to have a proximal attachment site that doesn’t interfere with renal flow.

     

    4. Should we invert the color and waveform when we see reversed flow throughout a vessel?

    It is vital that each vascular sonographer be able to determine flow direction in any vessel. If the flow is reversed in direction, it should be shown as reversed (blue) in both color and waveform so that anyone who looks at the image can see that there is reversal of flow. Then it can be determined as to why.

     

    5. What is the major concern in peripheral aneurysms?

    Blood clots and distal emboli.

     

    6. Which flow condition is the most common site for arterial disease development?

    Flow at branch points.

     

    7. What could be the cause of the spectral window filling on the PW doppler trace?

     There could be several causes:

    - Doppler gain is too high

    - Sample gate is placed at an area of flow separation

    - Reynold’s number is greater than 4000.

    The Role of Color Duplex After EVAR Q&A
    with Vascular Sonography Expert
    George Berdejo, BA, RVT, FSVU

    Educator and Vascular Sonographer
    \r\n White Planes, New York

    \r\n


    \r\nGeorge Berdejo has been in the vascular ultrasound field for almost 40 years and is currently the Director of Vascular Ultrasound Services at White Plains Hospital in White Plains, NY. He is a past President of SVU, Inaugural President of the SVU Foundation and Inaugural Chair of its DE&I Council. He serves as Co-Chair of the Annual Conference Committee and Chair of the AVID symposiums.
    \r\n

    \r\n"}}" id="text-be3a8cc9f6" class="8f00b2 cmp-text">

    Educator and Vascular Sonographer
    White Planes, New York


    George Berdejo has been in the vascular ultrasound field for almost 40 years and is currently the Director of Vascular Ultrasound Services at White Plains Hospital in White Plains, NY. He is a past President of SVU, Inaugural President of the SVU Foundation and Inaugural Chair of its DE&I Council. He serves as Co-Chair of the Annual Conference Committee and Chair of the AVID symposiums.

    George Berdejo, BA, RVT, FSVU

    1. When measuring aneurysms, do measurements in AP and TRANS or is it more correct to measure AP, TRANS, and LONG?

    Measurements are taken at the greatest diameter of the aorta (we generally eyeball this by using the transverse sweep of the aorta to identify the largest diameter). The aorta is imaged in the plane that is perpendicular to the long axis of the lumen and an anteroposterior (AP) measurement is obtained. We generally provide this measurement only although we do measure in the transverse dimension if the walls of the aorta are well defined. The measurement is from outer edge to outer edge.

    The aorta can also be scanned using a lateral or coronal approach if it cannot be visualized from an anterior transducer approach. The measurements obtained via these scan planes are equivalent to transverse measurements. We do not report on the length of a AAA.  

    2.  A significant advantage to DU over CTA is obviating the need for an IV infusion of a potentially nephrotoxic contrast agent and giving the patient a full abdominal dose of radiation.\r\n
    There is no doubt that DU has certain specific advantages over CTA for post EVAR evaluation.
    \r\n
    The obvious: CTA is not an ideal lifelong surveillance diagnostic tool due to the cumulative radiation exposure and the nephrotoxicity and allergic side effects associated with iodine contrast. Ultrasound is inexpensive compared to CT scans and some other imaging techniques. They're often relatively quick and easy to obtain. You typically don't need to prepare ahead of time for an ultrasound. It produces helpful and detailed images instantaneously.
    \r\n
    DU has been shown in multiple studies to be as or more sensitive to the presence and source of Type 2 endoleak than CTA, can assess residual aneurysm sac diameter as well and provides hemodynamic information that CTA does not. For these reasons, since lifelong surveillance is necessary for patients who have undergone EVAR DU is a better option.
    \r\n
    On the other hand, in addition to the evaluation of sac size, presence (or absence) and type of endoleak, CTA reports other anatomic features about the endograft that are important in pre-intervention planning that are not as reliably provided by DU (eg. endograft position in the aortic neck between the proximal end of the graft and renal arteries, graft displacement, information regarding stent-graft integrity, etc.
    \r\n
    Bottom line, both studies have limitations. I believe the techniques are complementary, however, color DU is better suited for routine long-term surveillance.
    \r\n
     
    \r\n

    3.  Any work on off label use of contrast imaging for technically difficult patients? Especially renal compromised patients?
    \r\n

    \r\n

    There may be a role for contrast enhanced ultrasound (CEUS), however I do not think this is true for routine surveillance especially in the context of stable/shrinking residual aneurysm sac size as studies have shown that non-contrast US is performing equal to or better than computed tomography for the detection and classification of endoleaks…in good hands.
    \r\nOne exception may be the patient with increasing aneurysm sac size with compromised renal function in whom the standard duplex scan does not detect endoleak. The CEUS may add information that was not seen. If there is a relatively recent prior CTA available, one might proceed directly to angiography for therapeutic purposes.

    \r\n

    Vector Flow has the potential to predict cardiovascular disease rather than simply diagnose and monitor progression. With advanced analysis tools such as Oscillatory Shear Index (a method of measuring turbulence of flow) and Wall Shear Stress (considered as a key factor for atherosclerosis development), this technology is on the forefront of predicting and quantifying vascular and neurovascular conditions.

    \r\n

     

    \r\n

    4.  Are some endoleaks more dangerous than others?

    \r\n

    •    Types 1 and 3 (direct pressure leaks) are the most dangerous because they have the highest risk of rupture.

    \r\n

    •    Type 2 endoleaks are the most common type of endoleak, accounting for approximately 50% of all endoleaks. However, they are usually benign and have a very low risk of rupture. Up to 90% of type 2 endoleaks resolve spontaneously or are not associated with sac enlargement. However, there is literature that suggests that a low-resistance, high-flow or to-fro flow type 2 endoleak has higher chances of sac enlargement, rupture, and requiring reintervention.

    \r\n

    •    Type V endoleaks are characterized by enlargement of the aneurysm after EVAR without visible blood flow in the aneurysmal sac by any of the imaging modalities. There is currently no consensus on how to manage type V endoleaks.

    \r\n

     

    \r\n

    5.  Do you change surveillance intervals according to the type of endoleak?

    \r\n

    We have in our practice. Types 1 and 3 (direct pressure leaks) generally go on to CTA scan and intervention.

    \r\n

    Type 2 with stable size/small increase who exhibit low-resistance, high-flow or to-fro flow type who have relative contraindications often are seen at shorter intervals to assess for aneurysm sac enlargement.

    \r\n

     

    \r\n

    6.  Does the presence of endoleak mean that the patient requires intervention?

    \r\n

    Type 1 and type 3 endoleaks are repaired in all instances because they represent direct communication of the aneurysm with the systemic circulation.

    \r\n

    Type 2 endoleak management is more varied, with roles for observation and embolization depending on changes in the residual aneurysm sac size.

    \r\n"}}" id="text-43a1b4558a" class="8f00b2 cmp-text">

    2.  A significant advantage to DU over CTA is obviating the need for an IV infusion of a potentially nephrotoxic contrast agent and giving the patient a full abdominal dose of radiation.

    There is no doubt that DU has certain specific advantages over CTA for post EVAR evaluation.
    The obvious: CTA is not an ideal lifelong surveillance diagnostic tool due to the cumulative radiation exposure and the nephrotoxicity and allergic side effects associated with iodine contrast. Ultrasound is inexpensive compared to CT scans and some other imaging techniques. They're often relatively quick and easy to obtain. You typically don't need to prepare ahead of time for an ultrasound. It produces helpful and detailed images instantaneously.
    DU has been shown in multiple studies to be as or more sensitive to the presence and source of Type 2 endoleak than CTA, can assess residual aneurysm sac diameter as well and provides hemodynamic information that CTA does not. For these reasons, since lifelong surveillance is necessary for patients who have undergone EVAR DU is a better option.
    On the other hand, in addition to the evaluation of sac size, presence (or absence) and type of endoleak, CTA reports other anatomic features about the endograft that are important in pre-intervention planning that are not as reliably provided by DU (eg. endograft position in the aortic neck between the proximal end of the graft and renal arteries, graft displacement, information regarding stent-graft integrity, etc.
    Bottom line, both studies have limitations. I believe the techniques are complementary, however, color DU is better suited for routine long-term surveillance.
     

    3.  Any work on off label use of contrast imaging for technically difficult patients? Especially renal compromised patients?

    There may be a role for contrast enhanced ultrasound (CEUS), however I do not think this is true for routine surveillance especially in the context of stable/shrinking residual aneurysm sac size as studies have shown that non-contrast US is performing equal to or better than computed tomography for the detection and classification of endoleaks…in good hands.
    One exception may be the patient with increasing aneurysm sac size with compromised renal function in whom the standard duplex scan does not detect endoleak. The CEUS may add information that was not seen. If there is a relatively recent prior CTA available, one might proceed directly to angiography for therapeutic purposes.

    Vector Flow has the potential to predict cardiovascular disease rather than simply diagnose and monitor progression. With advanced analysis tools such as Oscillatory Shear Index (a method of measuring turbulence of flow) and Wall Shear Stress (considered as a key factor for atherosclerosis development), this technology is on the forefront of predicting and quantifying vascular and neurovascular conditions.

     

    4.  Are some endoleaks more dangerous than others?

    •    Types 1 and 3 (direct pressure leaks) are the most dangerous because they have the highest risk of rupture.

    •    Type 2 endoleaks are the most common type of endoleak, accounting for approximately 50% of all endoleaks. However, they are usually benign and have a very low risk of rupture. Up to 90% of type 2 endoleaks resolve spontaneously or are not associated with sac enlargement. However, there is literature that suggests that a low-resistance, high-flow or to-fro flow type 2 endoleak has higher chances of sac enlargement, rupture, and requiring reintervention.

    •    Type V endoleaks are characterized by enlargement of the aneurysm after EVAR without visible blood flow in the aneurysmal sac by any of the imaging modalities. There is currently no consensus on how to manage type V endoleaks.

     

    5.  Do you change surveillance intervals according to the type of endoleak?

    We have in our practice. Types 1 and 3 (direct pressure leaks) generally go on to CTA scan and intervention.

    Type 2 with stable size/small increase who exhibit low-resistance, high-flow or to-fro flow type who have relative contraindications often are seen at shorter intervals to assess for aneurysm sac enlargement.

     

    6.  Does the presence of endoleak mean that the patient requires intervention?

    Type 1 and type 3 endoleaks are repaired in all instances because they represent direct communication of the aneurysm with the systemic circulation.

    Type 2 endoleak management is more varied, with roles for observation and embolization depending on changes in the residual aneurysm sac size.

    false